Advertisement
Screener

ATARA BIOTHERAPEUTICS, INC. (ATRA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ATARA BIOTHERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where ATARA BIOTHERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $50.94M went out.
  • Fiscal year ended 2025-12-31: from investing, $18.15M came in.
  • Fiscal year ended 2025-12-31: from financing, $16.10M came in.
  • Fiscal year ended 2025-12-31: change in cash, $16.69M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31-$50.94M$18.15M$1.47M-$1.00K$14.63M*-$16.69M
2024-12-31-$68.72M$8.62M$0.00$9.35M-$7.00K$49.94M*-$811.00K
2023-12-31-$192.98M$123.87M-$94.00K$2.14M-$13.00K-$67.10M
2022-12-31-$270.43M$202.96M-$623.00K$21.89M-$192.00K$32.01M*-$14.39M
2021-12-31-$220.52M$22.26M-$1.24M$98.70M-$17.00K$6.51M*-$94.32M
2020-12-31-$180.76M-$120.73M-$1.52M$69.19M-$165.00K$360.07M*$126.09M
2019-12-31-$235.63M$60.46M-$6.70M$47.73M$0.00$147.75M*$13.62M
2018-12-31-$179.77M-$196.29M-$7.50M$47.59M$0.00$317.45M*-$18.52M
2017-12-31-$87.50M$99.91M-$357.00K$19.16M$1.25M*$31.25M
2016-12-31-$60.02M$83.74M-$94.00K$0.00$600.00K*$24.22M
2015-12-31-$37.16M-$220.13M-$4.65M$263.43M$1.85M
2014-12-31-$16.63M-$83.36M$0.00$56.45M$13.82M*-$29.72M
2013-12-31-$5.97M-$3.00K$53.38M*$47.41M

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30-$3.34M*-$6.63M*$4.83M*
2026-03-31-$3.07M$0.00$2.95M-$122.00K
2025-12-31-$5.70M*$8.44M*-$25.00K*$0.00*
2025-09-30-$9.79M*-$2.42M*$1.50M*$0.00*
2025-06-30-$7.32M*-$5.07M*$0.00*$0.00*$15.30M*
2025-03-31-$28.14M$17.20M$0.00$0.00-$11.19M
2024-12-31-$24.47M*$3.38M*$0.00*$0.00*$0.00*
2024-09-30-$3.99M*-$16.66M*$0.00*$0.00*$0.00*$35.79M*
2024-06-30-$10.64M*$7.20M*$6.00K*-$26.00K*
2024-03-31-$29.61M$14.72M-$6.00K$9.37M$14.77M*$9.25M
2023-12-31-$50.41M*$9.94M*$0.00*$1.55M*$0.00*
2023-09-30-$51.35M*$70.45M*$0.00*$0.00*$0.00*
2023-06-30-$52.80M*$49.48M*-$1.00K*-$50.00K*-$13.00K*
2023-03-31-$38.43M-$6.01M-$93.00K$640.00K$0.00-$44.20M
2022-12-31-$56.88M*$51.22M*$0.00*$1.38M*-$37.00K*$30.95M*
2022-09-30-$65.06M*$59.70M*-$4.00K*$0.00*-$51.00K*
2022-06-30-$63.96M*$31.83M*-$3.00K*-$23.00K*$0.00*$1.18M*
2022-03-31-$84.53M$60.22M-$616.00K$20.54M-$104.00K-$4.46M
2021-12-31-$34.27M*-$24.32M*$0.00*$49.96M*$0.00*$1.51M*
2021-09-30-$58.98M*$1.19M*$0.00*$46.36M*$0.00*$780.00K*
2021-06-30-$61.58M*$31.89M*-$13.00K*-$75.00K*$0.00*$2.54M*
2021-03-31-$65.70M$13.50M-$1.23M*$2.46M-$17.00K-$49.31M
2020-12-31-$4.12M*-$36.89M*$0.00*$11.14M*$0.00*$167.65M*
2020-09-30-$52.96M*$7.56M*-$126.00K*$33.87M*$0.00*
2020-06-30-$56.64M*-$130.37M*$0.00*-$105.00K*$0.00*$191.42M*
2020-03-31-$67.04M$38.97M-$1.40M*$24.28M-$165.00K-$4.11M
2019-12-31-$58.69M*$1.13M*$0.00*$35.10M*$0.00*$2.35M*
2019-09-30-$52.15M*-$58.52M*-$25.00K*$5.00M*$0.00*$140.96M*
2019-06-30-$54.59M*$50.25M*-$2.10M*$7.63M*$0.00*
2019-03-31-$70.20M$67.60M-$4.58M$0.00$0.00$2.65M*-$4.53M
2018-12-31-$57.42M*$46.07M*-$10.00K*$0.00*$6.03M*
2018-09-30-$48.10M*$11.44M*-$4.06M*$0.00*$3.55M*
2018-06-30-$39.43M*-$3.88M*-$67.00K*-$245.70M*$301.79M*
2018-03-31-$34.82M-$249.92M-$3.36M$293.29M$6.08M*$11.27M
2017-12-31-$24.94M*$42.97M*-$6.00K*-$50.00K*$754.00K*$18.73M*
2017-09-30-$20.23M*$6.62M*-$10.00K*$9.88M*-$3.74M*
2017-06-30-$20.30M*$11.10M*-$15.00K*$9.33M*$1.81M*
2017-03-31-$22.03M$38.02M-$326.00K$0.00$14.46M
2016-12-31-$21.16M*$22.79M*-$19.00K*$0.00*$1.96M*
2016-09-30-$15.58M*$35.04M*-$22.00K*$0.00*$19.66M*
2016-06-30-$10.79M*$15.06M*-$21.00K*$15.00K*$4.30M*
2016-03-31-$12.49M$10.86M-$32.00K$14.00K-$1.69M
2015-12-31-$11.39M*-$19.42M*-$59.00K*$0.00*-$30.72M*
2015-09-30-$12.90M*-$152.89M*-$120.00K*$193.99M*$28.28M*
2015-06-30-$6.24M*-$34.39M*-$42.00K*-$4.47M*-$45.14M*
2015-03-31-$6.62M-$13.43M$69.49M$49.43M
2014-12-31-$4.96M*-$56.94M*$58.09M*-$3.81M*
2014-09-30-$4.09M*-$1.44M*-$548.00K*-$6.08M*
2014-06-30-$4.66M*-$2.58M*-$736.00K*-$7.97M*
2014-03-31-$2.92M-$22.41M$13.47M*-$11.86M
2013-12-31-$2.49M*$0.00*$38.41M*$35.92M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Vaxart, Inc. (VXRT)United States$0.080B3.84
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37